Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.730
-0.020 (-1.14%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edesa Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
6.00M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
IM Cannabis | 38.04M |
Ontrak | 11.24M |
Tenon Medical | 3.32M |
Intelligent Bio Solutions | 3.19M |
Mangoceuticals | 755.00K |
Addex Therapeutics | 701.26K |
EDSA News
- 8 days ago - Edesa Biotech Reports Fiscal Year 2024 Results - GlobeNewsWire
- 7 weeks ago - Edesa Biotech's Founder Makes Strategic Investment in the Company - GlobeNewsWire
- 2 months ago - Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewsWire
- 3 months ago - Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc. - GlobeNewsWire
- 4 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results - GlobeNewsWire
- 6 months ago - BARDA Selects Edesa Biotech's Drug for U.S. Funded Platform Trial in General ARDS - Accesswire
- 8 months ago - Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results - Accesswire
- 9 months ago - Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference - Accesswire